For clinical suspicion of CAH, we performed reverse dot blot and Multiple Ligation-dependent Probe Amplification (MLPA) of the CYP21A2 gene on the patients and her parents’ DNA. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.